亚虹医药 (688176)

Jiangsu Yahong Meditech Co., Ltd.

KSH

Tags

Loss-Making StocksInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareBiological ProductsBelow IPO PriceSTAR Market 200 IndexTechnology Growth LayerMargin Trading and Securities Lending医药生物Chemical Pharmaceuticals

K-Line Chart

No K-line data available

Company NameJiangsu Yahong Pharmaceutical Technology Co., Ltd.
Listing Date2022-01-07
Issue Price22.98RMB
Registered Capital57117.048610k RMB
Legal RepresentativePAN KE
Registered AddressRoom 1009, Building D, Phase II of the New Drug Creation Base, No. 1 Yaocheng Avenue (North of Yuannan Road, East of Chuangye Road), Taizhou, Jiangsu Province
IndustryChemical Pharmaceuticals
Main BusinessResearch and development of global innovative drugs in the fields of urogenital system, oncology, and other major diseases
Company ProfileYahong Pharmaceutical was founded in March 2010 and is a global innovative pharmaceutical company focused on urogenital system tumors and other major diseases. Adhering to the corporate mission of "Improving Human Health and Enhancing the Dignity of Life," Yahong aspires to become an international leading pharmaceutical enterprise integrating R&D, production, and commercialization in its focused therapeutic areas, providing the best integrated diagnosis and treatment solutions for patients in China and globally. The company insists on innovation technology and products as the core driving force. By building its own R&D platforms and core technologies, it deeply explores drug mechanisms of action and efficiently screens and evaluates candidate drugs. Leveraging its internal comprehensive R&D system and global drug development expertise, Yahong is committed to launching First-in-Class drugs and other innovative drugs addressing significant unmet medical needs in its focused therapeutic areas.

Stock Details

1. Key Indicators

  • Total Shares(W): No data
  • Circulating A-Shares(W): No data
  • Earnings Per Share(RMB): No data
  • Net Assets Per Share(RMB): No data
  • Operating Revenue(W RMB): No data
  • Total Profit(W RMB): No data
  • **Net Profit Attributable to Parent(W RMB) **: No data
  • Net Profit Growth Rate(%): No data
  • Weighted Return on Equity(%): No data
  • Operating Cash Flow Per Share(RMB): No data
  • Undistributed Profit Per Share(RMB): No data
  • Capital Reserve Per Share(RMB): No data

2. Main Business

The main business covers:

  • No data

3. Company Basic Information

  • Company Name: No data
  • Listing Date: No data
  • Industry: No data
  • Address: No data
  • Website: No data
  • Company Profile: No data

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
No data No data No data No data No data

5. Concept Sectors

  • Innovative Drugs
  • Margin Trading
  • Loss-Making Stocks
  • Consecutive Losses
  • Below IPO Price
  • Science and Technology Innovation Growth Layer
  • Science and Technology Innovation 200

Remarks

  • Data update date: Unknown
  • Data source: Public market information